• Return to Headlines

Shares of Endocyte Inc Rank the Lowest in Terms of Revenue Per Employee in the Pharmaceuticals Industry (ECYT, RVNC, ITCI, OCUL, DERM)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the lowest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Endocyte Inc ranks lowest with a an RPE of $2,000. Following is Revance Therapeu with a an RPE of $3,000. Intra-Cellular T ranks third lowest with a an RPE of $3,000.

Ocular Therapeut follows with a an RPE of $15,000, and Dermira rounds out the bottom five with a an RPE of $23,000.

SmarTrend is tracking the current trend status for Endocyte Inc and will alert subscribers who have ECYT in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest revenue per employee endocyte inc revance therapeu intra-cellular t ocular therapeut dermira

Ticker(s): ECYT RVNC ITCI OCUL DERM